These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1504038)

  • 41. X-ray absorption fine structure study of the active site of zinc and cobalt carboxypeptidase A in their solution and crystalline forms.
    Zhang K; Chance B; Auld DS; Larsen KS; Vallee BL
    Biochemistry; 1992 Feb; 31(4):1159-68. PubMed ID: 1734963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Native carboxypeptidase A in a new crystal environment reveals a different conformation of the important tyrosine 248.
    Bukrinsky JT; Bjerrum MJ; Kadziola A
    Biochemistry; 1998 Nov; 37(47):16555-64. PubMed ID: 9843422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Properties of analogues of an intermediate in the process of mechanism-based inactivation of carboxypeptidase A.
    Ghosh SS; Dakoji S; Tanaka Y; Cho YJ; Mobashery S
    Bioorg Med Chem; 1996 Sep; 4(9):1487-92. PubMed ID: 8894106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of thrombin receptor activation by thrombin receptor-derived heptapeptide with para-fluorophenylalanine in place of phenylalanine.
    Nose T; Shimohigashi Y; Ohno M; Costa T; Shimizu N; Ogino Y
    Biochem Biophys Res Commun; 1993 Jun; 193(2):694-9. PubMed ID: 8390250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carboxypeptidase A-catalyzed dipeptide synthesis in organic media.
    Vértesi A; Simon LM
    J Biotechnol; 1998 Nov; 66(1):75-82. PubMed ID: 9866861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three-dimensional structure of porcine pancreatic procarboxypeptidase A. A comparison of the A and B zymogens and their determinants for inhibition and activation.
    Guasch A; Coll M; Avilés FX; Huber R
    J Mol Biol; 1992 Mar; 224(1):141-57. PubMed ID: 1548696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methotrexate-alpha-phenylalanine: optimization of methotrexate prodrug for activation by carboxypeptidase A-monoclonal antibody conjugate.
    Vitols KS; Haag-Zeino B; Baer T; Montejano YD; Huennekens FM
    Cancer Res; 1995 Feb; 55(3):478-81. PubMed ID: 7834611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virtual screening for binding of phenylalanine analogues to phenylalanyl-tRNA synthetase.
    Wang P; Vaidehi N; Tirrell DA; Goddard WA
    J Am Chem Soc; 2002 Dec; 124(48):14442-9. PubMed ID: 12452720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enzymatic activities of carobxypeptidase A's in solution and in crystals.
    Lipscomb WN
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3797-801. PubMed ID: 4521205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zinc-mediated thermal stabilization of carboxypeptidase A.
    Li X; Solomon B
    Biomol Eng; 2001 Oct; 18(4):179-83. PubMed ID: 11576872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Halogen interactions in protein-ligand complexes: implications of halogen bonding for rational drug design.
    Sirimulla S; Bailey JB; Vegesna R; Narayan M
    J Chem Inf Model; 2013 Nov; 53(11):2781-91. PubMed ID: 24134121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular dynamics characterization of the active cavity of carboxypeptidase A and some of its inhibitor adducts.
    Banci L; Schröder S; Kollman PA
    Proteins; 1992 Aug; 13(4):288-305. PubMed ID: 1518800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antinociceptive effect of some carboxypeptidase A inhibitors in comparison with D-phenylalanine.
    Giusti P; Carrara M; Cima L; Borin G
    Eur J Pharmacol; 1985 Oct; 116(3):287-92. PubMed ID: 4076340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Halogenated ligands and their interactions with amino acids: implications for structure-activity and structure-toxicity relationships.
    Kortagere S; Ekins S; Welsh WJ
    J Mol Graph Model; 2008 Sep; 27(2):170-7. PubMed ID: 18524655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crystal structure of carboxypeptidase T from Thermoactinomyces vulgaris.
    Teplyakov A; Polyakov K; Obmolova G; Strokopytov B; Kuranova I; Osterman A; Grishin N; Smulevitch S; Zagnitko O; Galperina O
    Eur J Biochem; 1992 Sep; 208(2):281-8. PubMed ID: 1521526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases.
    Park JD; Kim DH; Kim SJ; Woo JR; Ryu SE
    J Med Chem; 2002 Nov; 45(24):5295-302. PubMed ID: 12431056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. X-ray crystallographic investigation of substrate binding to carboxypeptidase A at subzero temperature.
    Christianson DW; Lipscomb WN
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7568-72. PubMed ID: 3463986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Halogen bonds involved in binding of halogenated ligands by protein kinases.
    Poznański J; Winiewska M; Czapinska H; Poznańska A; Shugar D
    Acta Biochim Pol; 2016; 63(2):203-14. PubMed ID: 27104680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamical structure of carboxypeptidase A.
    Makinen MW; Troyer JM; van der Werff H; Berendsen HJ; van Gunsteren WF
    J Mol Biol; 1989 May; 207(1):201-16. PubMed ID: 2738924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1986 Jun; 35(12):1957-63. PubMed ID: 3718539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.